Truth, Lies, and False Memories: Neuroscience in the Courtroom

By Craig Stark, PhD


Craig Stark, Ph.D. Our constant exposure to over-inflated claims of what technologies like neuroimaging can do are leading to a form of collective false memory in the form of an unreasonable expectation of what the technology can prove. One of our series of Reports on Progress.



All About A4: An Important Test of Alzheimer’s Prevention

by Jim Schnabel

 Researchers, doctors, and patients await the results of the first clinical trial to prevent Alzheimer’s in ordinary elderly people. 



Sleep Deprivation Increases Susceptibility to False Memories

by Kayt Sukel

Learning false information when sleepy can change a person’s memory of a photograph, researchers find.



Placebo Effects Offer Window to Individual Differences in Treatment Response

By Jon-Kar Zubieta, MD, PhD

Rather than discounting placebo responses as irrelevant noise, we should instead investigate them as predictors of treatment response and as novel therapeutic targets in medication, device, or psychotherapeutic approaches to disease recovery. One of our series of Reports on Progress.



Target: Tau

by Jim Schnabel

Scientists have new insights into how the tau protein spreads within and harms the brain, in Alzheimer’s and other diseases--and tau-targeting therapies are now entering clinical trials.



The Brain Inflamed

by Jim Schnabel

Scientists are finding evidence that neuroinflammation can alter mood and cognition, perhaps enough to help cause psychiatric disorders.



Taking Out The Garbage: New Hope for Treating Neurodegeneration

by Kayt Sukel

Dementias, ALS, and Huntington’s show different outward symptoms, but researchers theorize the disease process may be similar—a buildup of proteins that normally are cleared away.



A Victory for Clinician Scientists

by Guy McKhann, MD

Guy_McKhann_thmbRecipients of a Lasker Award this year, Alim Louis Benabid and Mahlon DeLong are the epitome of clinical scientists, going from the patient to the laboratory and back to the patient. Clinical scientists just getting started in their careers can learn from them. From our free print publication, Brain in the News.



More Evidence That Vitamin D Protects Against Alzheimer’s

by Jim Schnabel

Lower vitamin D levels linked to higher dementia risk in two separate studies.



The Link Between Depression, Sleep, and Stress

by Moheb Costandi

Researchers discussed the molecular mechanisms linking sleep to depression and stress at the 9th FENS Forum of Neuroscience in Milan last month.



Closing the Gap Between Cochlear Implants and Natural Hearing

by Carl Sherman

Approaches include stimulating the growth of nerve fibers to improve sound perception and scanning the cortex to improve the device’s programming.



Can Hearing Loss Predict—or Lead to—Cognitive Decline?

by Jeremy Shere

Possible links between impaired hearing and loss of cognitive abilities raise the tantalizing possibility that restoring hearing could slow cognitive decline.



Why Studies of Fighting Fruit Flies Are Relevant to Understanding Human Aggression

By David J. Anderson, Ph.D.

Even though the brain of a fly doesn’t look like our own brain, it appears to follow certain basic principles in how it uses its neurons to control behavior, which may generalize to “higher” organisms, including humans. One of our series of Reports on Progress.



Autism Remains a Mystery, but Help May Be on the Horizon

AAAS Capitol Hill Briefing

As autism prevalence rises, early behavioral intervention is key, experts say, and insights on brain signaling could lead to new treatments. A report from a Capitol Hill briefing in July. See also links to video of the briefing.



The Neurobiology of Resilience

Brenda Patoine

Most drug development for depression has focused on undoing the bad effects of stress, but new research suggests that finding ways to induce resilience could lead to new treatments. One of our series of Briefing Papers.



Beyond Serotonin: Depression at the microRNA Level

by Kayt Sukel

Researchers focusing on glutamate pathways may have found a potential biomarker for the mood disorder.



Stem Cell Transplants Show Promise for Future Parkinson’s Treatments

by Kayt Sukel

Cells transplanted into brains of people with late-stage Parkinson’s remained functional for more than a decade after implant.



An Antidepressant to Prevent Alzheimer’s?

by Jim Schnabel

Scientists report promising results from a small clinical trial of an SSRI drug to lower amyloid beta levels, but years of further tests lie ahead.



Q&A: Music, Art, and Cognitive Benefit: Separating Fact from Fallacy

by Brenda Patoine

Spelke (headshot)

Dana grantee Elizabeth Spelke discusses the future direction of arts and cognition research, and puts into perspective the media attention given to her recently published study on the effects of music classes on math abilities in children. One of our series of Scientist Q & As.

 



FENS: How Far Should Brain Researchers Go?

by Moheb Costandi

How much should we enhance our brains, how far should we go to treat risky pre-term pregnancies, and when can we morally do research on people having surgery for something else were among the topics at the William Safire Seminar on Neuroethics.



Obesity Linked to Changes in Brain’s White Matter Structure—and Cognition

by Kayt Sukel

Reducing fat levels in obese mice through exercise or surgery appears to result in better cognitive performance.



Podcast: Alzheimer's Disease: Prospects for a Cure

By The New York Academy of Sciences

The search for a treatment for Alzheimer's Disease becomes increasingly urgent as global populations grow and age. In this podcast, leading experts from different sections of the research and development pipeline discuss cutting-edge approaches to developing treatments.



A Purposeful Life is a Healthier Life

by Moheb Costandi

Results from programs like Experience Corps suggest that having a goal or purpose helps protect against cognitive decline as we age.



‘Smart’ Drugs Alter Developing Brain

by Kayt Sukel

Though many “normal” people—students, lawyers, doctors—are taking drugs that may enhance cognitive function, there is little research into how these drugs affect non-disordered brains. A research review suggests that using cognitive-enhancing drugs may have unintended and quite negative consequences, especially in youngsters.



How Should We Be Thinking About Genetic Studies?

by Kayt Sukel

As the behavioral genetics field grows, we must be cautious not to oversimplify the research, warn experts, particularly in studies linking single genes to certain traits. One of our series of Briefing Papers.



A Fountain of Youth for the Brain?

by Jim Schnabel

Scientists have reported promising rejuvenation experiments on mouse brains-but it isn't clear that such results can be translated usefully into human therapies.



Using Optogenetics and Designer Receptors Exclusively Activated by Designer Drugs (DREADDs)

By Christie D. Fowler, Ph.D., Brian Lee, Ph.D., and Paul J. Kenny, Ph.D.

Techniques like optogenetics and DREADDs, which control neuronal activity, are revolutionizing our understanding of the central nervous system. Understanding each technique's advantages and disadvantages, and tailoring their use to best address the specific research question under consideration, is key. One of our series of Reports on Progress.



NIH Calls for ‘Sea Change’ Regarding Sex Differences in Research

by Kayt Sukel

New policy for US National Institutes of Health funding will require that researchers propose studies that have balance of male and female cells, tissues, or animals.



Uncovering the Mysteries of Myelin

by Kayt Sukel

Now that researchers have the technology to test the hypothesis that myelin is a simple, regular axonal insulator, they find it isn’t true. Now the fun begins.



The Neuroprotective Effects of Education

by Moheb Costandi

Research published in the past few years suggests that longer years of formal study can strengthen the brain, making it more resistant to the ravages of old age—and perhaps mitigating the damage that occurs after traumatic brain injury.



A Key Defender of the Aging Brain?

by Jim Schnabel

The loss of the REST protein from neurons appears to be an important early event in neurodegenerative disease. Researchers now are looking for ways to restore it in the elderly.



First Language Learned, Hearing Status Affects Brain Structure

by Kayt Sukel

Deaf people who learned American Sign Language first show differences in brain structure compared with deaf people who learned to lip-read English first.



Welcome to the Machine: Cerebrum Book Review

by Jerome Kagan

Cerebrum - May 2014 - book cover imageReviewer Jerome Kagan finds The Future of the Mind is intended not for skeptics but for the curious nonscientist who, like author Michio Kaku, enjoys Star Trek movies and H. G. Wells’s The War of the Worlds.



Glia: Earning Some Respect

by Carl Sherman

Either as “handmaidens to neurons” or as actors in their own right, glial cells show powerful effects in mouse models of disease.



Can Brain Scans Describe Good Leaders?

By Guy McKhann, MD

Guy_McKhann_thmbAs the political environment heats up, the leadership qualities of potential candidates are under the public microscope. Can advances in our understanding of the brain help assess a candidate’s leadership potential? Our monthly column from Brain in the News



Neuroimaging Offers Potential for Early Diagnosis of Neurodegenerative Disorders

by Kayt Sukel

Using DTI, researchers find brain “biomarkers” that identify who has the at-risk variation of a gene for a late onset fragile X-associated syndrome. Others are using PET scanning to track the plaques associated with Alzheimer’s years before symptoms show.



Gene Variants May Help Predict Recovery from TBI and PTSD

by Kayt Sukel

Researchers investigating the gene that directs the building of protein BDNF find that people with one variation seem to recover more slowly and less well than those with other variations.



Glycotoxicity: A New Risk Factor for Alzheimer’s?

by Jim Schnabel

Advanced glycation end-products from high-temperature cooking have already been linked to diabetes and heart disease, and scientists are now looking at their effects on the brain.



Protein May Offer Insights into Regenerating Brain Function After Injury

By Kayt Sukel

A single gene in the fruit fly does double duty, spurring neuron connections at larval stage and then again into mature fly. This gene is in humans, as well, but we don’t see a similar effect. Might we learn to reignite this gene’s regrowth properties to help injured people?



Q&A with Jane Nevins, Author of You’ve Got Some Explaining to Do

Jane_Nevins_80Dana Press editor-in-chief emerita Jane Nevins explains the differences between writing for the lay public versus scientist peers, how identifying the reader helps plot one’s narrative course, and why her new book, "You've Got Some Explaining to Do," extends to writers beyond those in the neuroscience community.



Alzheimer’s Early-Warning Biomarkers: Are We There Yet?

by Jim Schnabel

A recent finding of an Alzheimer’s early-warning “biomarker” needs replication, but researchers expect to have reliable ones before too long.



Gene-Environment Interactions in Parkinson’s Disease

By Paul Barrett, PhD, and J. Timothy Greenamyre, MD, PhD

Impairment of mitochondrial function may represent a critical choke point in the cascade of events that lead to PD. When people with a genetic predisposition toward imperfect mitochondria are exposed to certain toxins—whether natural or man-made— bad things may ensue, and this may result in PD. One of our series of Reports on Progress.



Brain Evolution: Neurogenomics Targets the Genes That Make Us Human

by Carl Sherman

Beyond basic science, researchers believe that identifying genes and gene expression patterns unique to humans may illuminate how higher cognitive processes go wrong—and suggest treatments for disorders like autism and schizophrenia.



Are Face-Blindness and Synesthesia Linked to Autism Spectrum Disorders?

by Lauren Arcuri Ware

Both perceptual conditions occur at higher rates in people with autism. Teasing out why could help explain how all our brains process such information.



Older, Slower—But Wiser?

by Jim Schnabel

Two new studies reinterpret classic signs of cognitive decline.



The Solitary Brain

by Moheb Costandi

While the use of solitary confinement in US prisons has grown in recent decades, so has research showing its lasting harmful effects.



BAW Partner Interview: Kelley Remole

from the Dana blog

Remole Columbia-NeuroscienceKelley Remole, director of neuroscience outreach at Columbia University and co-president of the Greater NYC Chapter of the Society for Neuroscience, describes the inaugural year of BraiNY and reminds us, "you don’t know what you’re capable of until you try." science—from labs to public plazas and parks.



BAW Partner Interview: Norberto Garcia-Cairasco

from the Dana blog

Garcia-Cairasco - BAWNorberto Garcia-Cairasco, director of Neurophysiology and Experimental Neuroethology Laboratory (LNNE) at Ribeirão Preto School of Medicine at the University of São Paulo, Brazil, describes the power of networks in spreading the word on brain science—from labs to public plazas and parks.



BAW Partner Interview: Michael Friedlander

from the Dana blog

michael friedlander - thumbnailMichael Friedlander, Ph.D., the mastermind behind Brain School, a public lecture series in which VTCRI's faculty members offered an owner’s manual on the brain, talks about how to target audiences and run great events. Their other events last year included "Mythbusters: the truth about your brain" for kids and "Food for Thought: chefs celebrate Brain Awareness Week" for foodies.



Get to Know Your BRAIN

By Guy McKhann, MD

The federal BRAIN Initiative is a worthwhile endeavor, but there are reasons to be skeptical of its potential impact, says Guy McKhann, professor of neurology and neuroscience at Johns Hopkins University. Our monthly column from Brain in the News